Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for SRPT

Stock NameSarepta Therapeutics Inc
TickerSRPT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS8036071004
LEI549300IKDPIED8J8IG21

Show aggregate SRPT holdings

News associated with SRPT

Leerink Partners Boosts Sarepta Therapeutics (NASDAQ:SRPT) Price Target to $15.00
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target raised by analysts at Leerink Partners from $12.00 to $15.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “market perform” rating on the biotechnology company’s stock. Leerink Partners’ price target would indicate a potential downside of 12.89% from the stock’s […] - 2025-09-11 03:04:49
After Hours Most Active for Aug 29, 2025 : ELAN, NVDA, GOOG, PPBI, SRPT, COLB, MSFT, SNAP, KMI, XOM, NEE, PFE
The NASDAQ 100 After Hours Indicator is down -7.17 to 23,408.25. The total After hours volume is currently 173,977,891 shares traded.The following are the most active stocks for the after hours session: Elanco Animal Health Incorporated (ELAN) is unchanged at $18.35, with 22,912 - 2025-08-29 17:29:12
HC Wainwright Reiterates “Sell” Rating for Sarepta Therapeutics (NASDAQ:SRPT)
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “sell” rating reiterated by equities research analysts at HC Wainwright in a report released on Monday,Benzinga reports. A number of other research firms have also issued reports on SRPT. Barclays raised shares of Sarepta Therapeutics from an “underweight” rating to an “equal weight” rating and […] - 2025-08-27 02:30:45
SCHK's Underlying Holdings Could Mean 11% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:39:22
Sarepta Therapeutics (NASDAQ:SRPT) Given New $17.00 Price Target at Bank of America
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price objective lifted by Bank of America to $17.00 in a research note issued to investors on Wednesday,Benzinga reports. They currently have an underperform rating on the biotechnology company’s stock. Other equities analysts have also issued reports about the company. Baird R W lowered Sarepta Therapeutics from […] - 2025-08-21 04:58:48
Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $12.00
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price objective hoisted by Deutsche Bank Aktiengesellschaft to $12.00 in a research note released on Friday,Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a sell rating on the biotechnology company’s stock. Other research analysts have also issued reports about the stock. TD Cowen lowered shares of Sarepta Therapeutics […] - 2025-08-18 03:06:45
Vanguard Group Inc. Decreases Stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Vanguard Group Inc. lowered its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 0.6% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 9,032,613 shares of the biotechnology company’s stock after selling 52,843 shares during the quarter. Vanguard Group Inc. owned about 0.09% […] - 2025-08-14 04:37:10
Stocks Rally on Positive Tariff News ad Rate Cut Hopes
The S&P 500 Index ($SPX ) (SPY ) today is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.71%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures... - 2025-08-07 18:57:35
Stocks Rally on Positive Tariff News ad Rate Cut Hopes
The S&P 500 Index ($SPX ) (SPY ) today is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.71%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures... - 2025-08-07 13:11:34
Stocks Rally on Positive Tariff News ad Rate Cut Hopes
The S&P 500 Index ($SPX ) (SPY ) today is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.71%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures... - 2025-08-07 12:48:17
Stocks Rally on Positive Tariff News ad Rate Cut Hopes
The S&P 500 Index ($SPX ) (SPY ) today is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.71%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures... - 2025-08-07 12:41:53
Barclays Upgrades Sarepta Therapeutics (NASDAQ:SRPT) to “Equal Weight”
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research report issued to clients and investors on Tuesday, MarketBeat.com reports. The firm currently has a $22.00 target price on the biotechnology company’s stock. Barclays‘s price objective indicates a potential upside […] - 2025-07-31 05:26:59
Sarepta Therapeutics (NASDAQ:SRPT) Stock Rating Upgraded by Barclays
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by research analysts at Barclays from an “underweight” rating to an “equal weight” rating in a report released on Tuesday, MarketBeat Ratings reports. The brokerage presently has a $22.00 target price on the biotechnology company’s stock. Barclays‘s price target would indicate a potential upside of 35.38% […] - 2025-07-31 05:26:59
Sarepta Therapeutics (NASDAQ:SRPT) Upgraded to Equal Weight at Barclays
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by stock analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research note issued on Tuesday, Marketbeat reports. The brokerage presently has a $22.00 price target on the biotechnology company’s stock. Barclays‘s price objective points to a potential upside of 31.34% […] - 2025-07-31 05:26:59
BMO Capital Markets Forecasts Strong Price Appreciation for Sarepta Therapeutics (NASDAQ:SRPT) Stock
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target hoisted by BMO Capital Markets from $25.00 to $50.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “market perform” rating on the biotechnology company’s stock. BMO Capital Markets’ price objective would indicate a potential upside of 198.51% from the stock’s […] - 2025-07-31 05:26:58
William Blair Reaffirms “Outperform” Rating for Sarepta Therapeutics (NASDAQ:SRPT)
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “outperform” rating reissued by investment analysts at William Blair in a research report issued on Tuesday,RTT News reports. Other equities analysts have also recently issued reports about the stock. Bank of America reaffirmed an “underperform” rating on shares of Sarepta Therapeutics in a report on […] - 2025-07-31 05:26:58
Sarepta Therapeutics (NASDAQ:SRPT) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price objective hoisted by equities researchers at Morgan Stanley from $15.00 to $20.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the biotechnology company’s stock. Morgan Stanley’s price target suggests a potential upside of 19.40% from the stock’s […] - 2025-07-31 03:02:52
HC Wainwright Reaffirms Sell Rating for Sarepta Therapeutics (NASDAQ:SRPT)
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “sell” rating restated by analysts at HC Wainwright in a note issued to investors on Tuesday, MarketBeat.com reports. A number of other equities research analysts also recently commented on SRPT. Piper Sandler reduced their price objective on shares of Sarepta Therapeutics from $32.00 to $18.00 […] - 2025-07-31 03:02:51
Sarepta Therapeutics (NASDAQ:SRPT) Stock Rating Upgraded by JPMorgan Chase & Co.
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by equities researchers at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage currently has a $24.00 target price on the biotechnology company’s stock. JPMorgan Chase & Co.‘s price target […] - 2025-07-31 03:02:51
Stocks Retreat Ahead of Results from Wednesday's FOMC Meeting
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. September E-mini S&P futures (ESU25 ) fell -0.30%, and September E-mini Nasdaq futures (NQU25... - 2025-07-30 12:49:47
Stocks Retreat Ahead of Results from Wednesday's FOMC Meeting
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. September E-mini S&P futures (ESU25 ) fell -0.30%, and September E-mini Nasdaq futures (NQU25... - 2025-07-30 08:23:02
Sarepta Therapeutics (NASDAQ:SRPT) Earns “Underperform” Rating from Needham & Company LLC
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “underperform” rating reaffirmed by Needham & Company LLC in a report issued on Monday,Benzinga reports. Several other equities analysts have also recently issued reports on SRPT. Scotiabank raised Sarepta Therapeutics from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price […] - 2025-07-30 04:54:53
Barclays Downgrades Sarepta Therapeutics (NASDAQ:SRPT) to Strong Sell
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was downgraded by equities research analysts at Barclays from a “hold” rating to a “strong sell” rating in a report released on Monday, MarketBeat Ratings reports. Other research analysts have also recently issued research reports about the stock. HC Wainwright reaffirmed a “sell” rating on shares of Sarepta […] - 2025-07-30 04:54:51
Stocks Retreat Ahead of Results from Wednesday's FOMC Meeting
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. September E-mini S&P futures (ESU25 ) fell -0.30%, and September E-mini Nasdaq futures (NQU25... - 2025-07-30 03:41:41
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up Following Analyst Upgrade
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) shares gapped up before the market opened on Tuesday after Barclays upgraded the stock from an underweight rating to an equal weight rating. The stock had previously closed at $13.86, but opened at $18.23. Barclays now has a $22.00 price target on the stock. Sarepta Therapeutics shares […] - 2025-07-30 02:14:47
Strong Earnings and Trade Deal Optimism Bolster Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.56%. September E-mini S&P futures (ESU25 ) are up +0.15%, and September E-mini Nasdaq futures... - 2025-07-29 20:49:20
Stocks Slide in Afternoon Session
The S&P 500 Index ($SPX ) (SPY ) today is down -0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.25%. After starting off the day stronger, the 3 major stock indxes are in the... - 2025-07-29 20:19:00
Stocks Supported by Strong Earnings and Trade Deal Optimism
The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. September E-mini S&P futures (ESU25 ) are up +0.03%, and September E-mini Nasdaq futures... - 2025-07-29 14:38:53
Stocks Supported by Strong Earnings and Trade Deal Optimism
The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. September E-mini S&P futures (ESU25 ) are up +0.03%, and September E-mini Nasdaq futures... - 2025-07-29 14:12:43
Strong Earnings and Trade Deal Optimism Bolster Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.56%. September E-mini S&P futures (ESU25 ) are up +0.15%, and September E-mini Nasdaq futures... - 2025-07-29 14:12:42

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) SRPT holdings

DateNumber of SRPT Shares HeldBase Market Value of SRPT SharesLocal Market Value of SRPT SharesChange in SRPT Shares HeldChange in SRPT Base ValueCurrent Price per SRPT Share HeldPrevious Price per SRPT Share Held
2025-11-11 (Tuesday)62,694USD 1,127,238USD 1,127,238
2025-11-10 (Monday)62,694SRPT holding increased by 161USD 1,082,725SRPT holding decreased by -19732USD 1,082,725161USD -19,732 USD 17.27 USD 17.63
2025-11-07 (Friday)62,533USD 1,102,457SRPT holding decreased by -625USD 1,102,4570USD -625 USD 17.63 USD 17.64
2025-11-06 (Thursday)62,533SRPT holding increased by 161USD 1,103,082SRPT holding decreased by -61403USD 1,103,082161USD -61,403 USD 17.64 USD 18.67
2025-11-05 (Wednesday)62,372SRPT holding increased by 161USD 1,164,485SRPT holding increased by 156667USD 1,164,485161USD 156,667 USD 18.67 USD 16.2
2025-11-04 (Tuesday)62,211USD 1,007,818SRPT holding decreased by -513241USD 1,007,8180USD -513,241 USD 16.2 USD 24.45
2025-11-03 (Monday)62,211USD 1,521,059SRPT holding increased by 27373USD 1,521,0590USD 27,373 USD 24.45 USD 24.01
2025-10-31 (Friday)62,211USD 1,493,686SRPT holding increased by 47280USD 1,493,6860USD 47,280 USD 24.01 USD 23.25
2025-10-30 (Thursday)62,211SRPT holding increased by 805USD 1,446,406SRPT holding increased by 6435USD 1,446,406805USD 6,435 USD 23.25 USD 23.45
2025-10-29 (Wednesday)61,406SRPT holding increased by 322USD 1,439,971SRPT holding decreased by -39483USD 1,439,971322USD -39,483 USD 23.45 USD 24.22
2025-10-28 (Tuesday)61,084USD 1,479,454SRPT holding increased by 43980USD 1,479,4540USD 43,980 USD 24.22 USD 23.5
2025-10-27 (Monday)61,084USD 1,435,474SRPT holding increased by 42148USD 1,435,4740USD 42,148 USD 23.5 USD 22.81
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SRPT by Blackrock for IE00BYXG2H39

Show aggregate share trades of SRPT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY161 17.270* 64.60
2025-11-06BUY161 17.640* 65.08
2025-11-05BUY16118.80016.580 16.802USD 2,705 65.31
2025-10-30BUY80523.39022.788 22.848USD 18,393 66.21
2025-10-29BUY32223.45024.040 23.981USD 7,722 66.44
2025-10-22SELL-64422.47023.720 23.595USD -15,195 67.60 Profit of 28,338 on sale
2025-10-20BUY32223.05023.730 23.662USD 7,619 68.08
2025-10-17BUY80422.51022.990 22.942USD 18,445 68.33
2025-10-15BUY1,28022.20022.260 22.254USD 28,485 68.58
2025-10-03BUY1,12722.64022.950 22.919USD 25,830 69.09
2025-10-02BUY16122.35023.420 23.313USD 3,753 69.35
2025-09-30BUY32219.27019.340 19.333USD 6,225 69.91
2025-09-26BUY32418.36018.390 18.387USD 5,957 70.50
2025-09-25BUY32417.72018.240 18.188USD 5,893 70.80
2025-09-24SELL-2,56318.26018.460 18.440USD -47,262 71.10 Profit of 134,969 on sale
2025-09-18BUY16918.52018.550 18.547USD 3,134 71.40
2025-09-17BUY51017.05018.140 18.031USD 9,196 71.72
2025-09-05SELL-16918.71019.270 19.214USD -3,247 72.67 Profit of 9,034 on sale
2025-08-20SELL-67620.58020.660 20.652USD -13,961 73.63 Profit of 35,814 on sale
2025-07-30BUY67216.75019.240 18.991USD 12,762 75.69
2025-07-17SELL-33621.97022.860 22.771USD -7,651 79.33 Profit of 19,004 on sale
2025-07-11SELL-1,35218.17018.950 18.872USD -25,515 80.99 Profit of 83,979 on sale
2025-07-07BUY50717.32018.270 18.175USD 9,215 82.73
2025-07-02BUY9,29518.20018.350 18.335USD 170,424 83.64
2025-06-20BUY2,02220.08020.880 20.800USD 42,058 84.10
2025-06-11BUY32237.81039.640 39.457USD 12,705 87.06
2025-06-10BUY32239.07040.900 40.717USD 13,111 87.42
2025-06-04SELL-16139.54040.280 40.206USD -6,473 88.89 Profit of 7,838 on sale
2025-04-23BUY16159.49062.780 62.451USD 10,055 102.29
2025-04-10SELL-1,28850.31054.470 54.054USD -69,622 107.17 Profit of 68,408 on sale
2025-04-08SELL-16149.30055.360 54.754USD -8,815 108.42 Profit of 8,641 on sale
2025-04-07SELL-16152.40055.170 54.893USD -8,838 109.07 Profit of 8,723 on sale
2025-04-04SELL-80554.43059.450 58.948USD -47,453 109.72 Profit of 40,869 on sale
2025-04-01BUY1,40361.91065.690 65.312USD 91,633 110.86
2025-03-31SELL-47463.82067.470 67.105USD -31,808 111.44 Profit of 21,013 on sale
2025-03-21BUY2,77874.10075.500 75.360USD 209,350 114.46
2025-03-14SELL-2,38497.190100.000 99.719USD -237,730 116.52 Profit of 40,061 on sale
2025-03-07SELL-298103.030104.850 104.668USD -31,191 117.75 Profit of 3,899 on sale
2025-03-04SELL-149102.860103.590 103.517USD -15,424 118.34 Profit of 2,209 on sale
2025-02-25BUY298106.950107.110 107.094USD 31,914 119.49
2025-02-19SELL-149107.120107.460 107.426USD -16,006 120.43 Profit of 1,938 on sale
2025-02-13BUY447109.460110.110 110.045USD 49,190 121.45
2025-02-12BUY149109.810110.340 110.287USD 16,433 121.69
2025-02-11BUY596109.680111.590 111.399USD 66,394 121.94
2024-12-30SELL-5,422121.190121.630 121.586USD -659,239 124.56 Profit of 16,145 on sale
2024-11-18SELL-2,460104.670105.980 105.849USD -260,389 126.17 Profit of 49,988 on sale
2024-11-08SELL-164121.610121.960 121.925USD -19,996 127.34 Profit of 888 on sale
2024-10-30BUY217127.780130.850 130.543USD 28,328 129.89
2024-10-21SELL-163127.310129.240 129.047USD -21,035 0.00 Loss of -21,035 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SRPT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19983,56911,5822,229,35644.1%
2025-09-181,090,47513,2562,892,18137.7%
2025-09-171,084,43212,6462,880,08537.7%
2025-09-16894,02124,7942,572,51634.8%
2025-09-15965,39017,4131,966,97649.1%
2025-09-12653,9584,4501,496,52443.7%
2025-09-111,072,91220,7792,821,71038.0%
2025-09-101,151,23526,9382,519,73145.7%
2025-09-09912,3845,7001,971,30846.3%
2025-09-081,691,08614,2363,124,45754.1%
2025-09-05983,68832,9292,352,17841.8%
2025-09-04914,1254,0941,995,50145.8%
2025-09-031,510,13728,0813,442,47743.9%
2025-09-021,295,4201,7422,645,87349.0%
2025-08-291,216,3688,5982,467,99249.3%
2025-08-281,059,0254,6452,463,62643.0%
2025-08-271,514,6362132,902,51252.2%
2025-08-261,565,99849,8953,527,43544.4%
2025-08-252,838,9585,2296,270,84045.3%
2025-08-221,981,78231,8414,688,70342.3%
2025-08-214,086,13090,9177,046,33158.0%
2025-08-201,278,7054,5102,928,74143.7%
2025-08-19876,3141,4942,229,42439.3%
2025-08-181,204,4303,0102,779,04043.3%
2025-08-151,705,8679,1864,100,04041.6%
2025-08-141,349,4418353,381,57939.9%
2025-08-131,545,26520,7605,282,33129.3%
2025-08-121,305,8382,5073,231,12540.4%
2025-08-112,168,6739,1525,077,98542.7%
2025-08-082,133,50314,9324,694,28445.4%
2025-08-073,771,97442,4797,573,97949.8%
2025-08-062,783,5034,4765,375,05551.8%
2025-08-051,594,8466763,432,44546.5%
2025-08-044,127,0573,7787,480,14955.2%
2025-08-012,097,7514,0354,221,31849.7%
2025-07-313,263,53232,1437,100,48946.0%
2025-07-308,885,53612,37218,507,33748.0%
2025-07-2917,694,15467,60830,461,99558.1%
2025-07-284,761,652590,3969,578,71049.7%
2025-07-252,445,819120,8785,876,92241.6%
2025-07-249,985,202652,75020,571,46348.5%
2025-07-231,525,8395,3074,030,26637.9%
2025-07-224,478,481383,13310,024,47644.7%
2025-07-213,426,18878,3209,225,50637.1%
2025-07-1811,983,277545,93629,286,07140.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.